Search Results - "Kang, HyungGyoo"

Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface Receptor by Federman, Noah, Chan, Jason, Nagy, Jon O., Landaw, Elliot M., McCabe, Katelyn, Wu, Anna M., Triche, Timothy, Kang, HyungGyoo, Liu, Bin, Marks, James D., Denny, Christopher T.

“…Osteosarcoma is the most common primary malignancy of bone in children, adolescents, and adults. Despite extensive surgery and adjuvant aggressive high-dose…”
Get full text

Abstract 1717: Targeted NanoSpheres (TNS): An effective, non-toxic nano-formulated therapeutic platform for broad use in cancer treatment by Kang, Hyunggyoo, Nagy, Jon, Triche, Timothy

“…Current cancer therapy relies on the use of cytotoxic agents (‘chemotherapy') that was developed over 50 years ago. These agents are very effective, but…”
Get full text

Abstract 312: Targeted NanoSpheres (TNS) by Kang, HyungGyoo, Nagy, Jon, Upton, Bryon, Upton, Racheal, Triche, Timothy

“…The tumor-targeted, nanoparticle delivery technology has shown the possibility of increasing the delivered dose of virtually any small therapeutics to tumor…”
Get full text

Abstract 3705: Targeted anticancer drug delivery to Ewing's sarcoma using human anti-CD99 targeted hybrid polymerization liposomal nanoparticles by Kang, Hyunggyoo, Nagy, Jon, Triche, Timothy

“…Most anticancer therapies are unspecific and therefore inevitably lead to off-target toxicity. To overcome these shortcomings, targetable hybrid polymerization…”
Get full text

Abstract 2875: Targeted therapy of Ewing’s sarcoma by human anti CD99 targeted hybrid polymerized liposomal nanoparticles (HPLNs) encapsulating anticancer agents by Kang, HyungGyoo, Nagy, Jon, Mitra, Sheetal, Triche, Triche

“…Most anticancer therapies are unspecific and therefore inevitably lead to off-target toxicity. To overcome these shortcomings, targetable hybrid polymerization…”
Get full text

Abstract 2695: Targeted therapy of leukemia and Ewing's sarcoma by human antibody-targeted nanoparticles by Kang, Hyunggyoo, Nagy, Jon, Trivhe, Timothy

“…Current cancer therapies have shown limited success due to the poor selectivity. The recent chemotherapy could be far more effective if higher doses could be…”
Get full text

Abstract 3206: Tumor-targeted nanoparticles for cancer therapy by Kang, HyungGyoo, Upton, Bryon, Nagy, Jon, Triche, Timothy

“…Introduction: Untargeted cancer therapy is often toxic, limiting the maximum tolerated dose (MTD) and thus potential cure. Targeted therapy with antibody-drug…”
Get full text

Abstract 695: Targeted nanoparticle therapy for poor prognosis Ewing’s sarcoma by Kang, HyungGyoo, Nagy, Jon, Samulak, Julia, Triche, Timothy

“…Targeted nanoparticles have shown the potential to deliver anticancer drugs to cancer cells selectively and thus to overcome unexpected cytotoxicity and…”
Get full text

Abstract 295: Superior efficacy of targeted nanoparticle therapy for brain tumors by Kang, HyungGyoo, Nagy, Jon, Upton, Bryon, Triche, Timothy

“…Glioblastoma Multiforme is an incurable malignant brain tumor. Despite intensive efforts over many years, the prognosis is essentially unchanged. The primary…”
Get full text

Abstract 1623: Targeted therapy of Ewing's Sarcoma and childhood leukemia (ALL) by hybrid polymerized liposomal nanoparticles (HPLN) by Kang, Hyunggyoo, Shahbazian, Violette, Holly, Ryan, Nagy, Jon, Triche, Timothy

“…Poor selectivity of the current cancer therapies causes a variety of side effects such as secondary cancers, heart or lung damage, infertility or chronic…”
Get full text

Abstract 825: Targeted nanospheres for the treatment of cancer by Kang, HyungGyoo, Upton, Bryon, Scott, Paul, Lewis, Mark, Nagy, Jon, Triche, Timothy

“…Conventional cancer therapy exploits sensitivity of dividing cells to DNA damage leading to apoptosis and tumor kill. Off-target normal tissue toxicity limits…”
Get full text

Abstract 5424: Development of selective therapy of childhood ALL and Ewing's sarcoma using targeted-hybrid polymerized liposomal nanoparticles (HPLN) by Kang, Hyunggyoo, Shahbazian, Violette, Schafenacker, Amanda, Nagy, Jon, Triche, Timothy

“…Until now a lot of understanding and research of cancer biology can make it possible to develop many anticancer drugs which can inhibit the specific pathways…”
Get full text

Abstract 2750: Targeted therapy of childhood ALL and Ewing's sarcoma using antiCD19 (antiCD99)-Hybrid Polymerized Liposomal Nanoparticles (HPLN) by Kang, HyungGyoo, Shahbazian, Violette, Nagy, Jon, Triche, Timothy

“…Current success in childhood cancer therapy improves the survival rate of patients but unfortunately not all childhood cancers have shown successful survival…”
Get full text

Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface Receptor by Denny, Christopher T., Marks, James D., Kang, HyungGyoo, Triche, Timothy, Wu, Anna M., McCabe, Katelyn E., Landaw, Elliot M., Nagy, Jon O., Chan, Jason, Federman, Noah, Liu, Bin

“…Osteosarcoma is the most common primary malignancy of bone in children, adolescents, and adults. Despite extensive surgery and adjuvant aggressive high-dose…”
Get full text